Skip to main content
SpringerLink
Log in

One-molar gadolinium chelate (gadobutrol) as a contrast agent for CT angiography of the thoracic and abdominal aorta

  • Vascular-Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The aim of our study was to evaluate the use of a 1-molar gadolinium chelate (gadobutrol) as an alternative contrast medium for computed tomography angiography (CTA) exams of the aorta. CTA exams of the thoracic and/or abdominal aorta were performed on 15 patients with contraindications for the use of iodine who were not suitable for magnetic resonance examinations. The exams were performed with a 16-detector row scanner, injecting a mean dose of 0.37 mmol Gd/kg of body weight at a flow rate of 4 ml/s. Creatinine levels were obtained prior to the exam in patients with impaired renal function, and 24 and 48 h afterwards. The mean attenuation values obtained in the middle ascending and middle descending thoracic aorta were 202.3 and 216.8, respectively. The mean HU values of the abdominal aorta were 210.4 at the level of the renal arteries and 186.8 in the aortic bifurcation. All the exams were considered diagnostically adequate. No significant increase in serum creatinine was observed 24 and 48 h after the exam. We believe that gadobutrol could be an alternative contrast medium for CTA exams with 16-detector row scanners in patients with contraindications for iodinated contrast medium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Janon EA (1989) Gadolinium-DTPA: a radiographic contrast agent. Am J Roentgenol 152:1348

    CAS  Google Scholar 

  2. Bloem JL, Wondergem J (1989) Gd-DTPA as a contrast agent in CT. Radiology 171:578–579

    PubMed  CAS  Google Scholar 

  3. Luboldt W, De Santis M, Von Smekal A, Reiser M (1997) Attenuation characteristics and application of gadolinium-DTPA in fast helical computed tomography. Invest Radiol 35:690–695

    Article  Google Scholar 

  4. Gierada DS, Bae KT (1999) Gadolinium as a CT contrast agent: assessment in a porcine model. Radiology 210:829–834

    PubMed  CAS  Google Scholar 

  5. Niendorf H, Dinger J, Haustein J, Cornelius I, Alhassan A, Clauss W (1991) Tolerance of Gd-DTPA: a review. Eur J Radiolo 13:15–20

    Article  CAS  Google Scholar 

  6. Prince MR, Arnoldus C, Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. JMRI 6:162–166

    Article  PubMed  CAS  Google Scholar 

  7. Kuhtz-Buschbeck JP, Ehrhardt K, Köhnlein S, Radtke W, Heintzen P (1997) Gadopentate dimeglumine and iodinated contrast media: hemodynamic side effects after bolus injection in pigs. Invest Radiol 32:111–119

    Article  PubMed  CAS  Google Scholar 

  8. Rieger J, Sitter T, Toepfer M, Lisenmaier U, Pfeifer KJ, Schiff H (2002) Gadolinium as an alternative contrast agent for diagnostic and interventional procedures in patients with impaired renal function. Nephrol Dial Trasplant 17:824–828

    Article  Google Scholar 

  9. Kinno Y, Odagiri K, Andoh K, Itoh I, Tarao K (1993) Gadopentate dimeglumine as an alternative contrast agent for the use in angiography. AJR AM J Roentgenol 16:1293–1294

    Google Scholar 

  10. Spinosa D, Matsumoto A, Angle J, Hagspiel KD (1998) Use of gadopentate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement. Kidney Int 53:503–507

    Article  PubMed  CAS  Google Scholar 

  11. Spinosa DJ, Kaufmann JA, Hartwell GD (2002) Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 223:319–325

    Article  PubMed  CAS  Google Scholar 

  12. Hammer FD, Malaise J, Goffette PP, Mathurin P (2000) Gadolinium dimeglumine : an alternative contrast agent for digital subtraction angiography in patients with renal failure. Trasplant Proc 32:432–433

    Article  CAS  Google Scholar 

  13. Wagner HJ, Kalinowski M, Klose KJ, Alfke H (2001) The use of gadolinium-chelates for X-ray digital subtraction angiography. Invest Radiol 36:257–265

    Article  PubMed  CAS  Google Scholar 

  14. Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878–882

    PubMed  CAS  Google Scholar 

  15. Priebe M, Mohr A, Brossmann J, Heller M, Frahm C (2002) Gadobutrol: an altetrnative contrast agent for digital subtraction dacryosystography. Eur Radiol 12:2083–2086

    PubMed  CAS  Google Scholar 

  16. Pena CS, Kaufman JA, Geller SC, Waltman AC (1999) Gadopentetate dimeglumine: a possible alternative contrast for CT angiography of the aorta. J Comput Assist Tomogr 23:23–24

    Article  PubMed  CAS  Google Scholar 

  17. Coche EE, Hammer FD, Goffette PP (2001) Demonstration of pulmonary embolism with gadolinium-enhanced spiral CT. Eur Radiol 11:2306–2309

    Article  PubMed  CAS  Google Scholar 

  18. Gupta AK, Alberico A, Litwin A, Kanter P, Grossman ZD (2002) Gadopentetate dimeglumine is potentially an alternative contrast agent for three-dimensional computed tomography angiography with multidetector-row helical scanning. J Comput Assist Tomogr 26:869–874

    Article  PubMed  Google Scholar 

  19. Karcaaltincaba M, Foley D (2002) Gadolinium.enhanced multidetector CT angiography of the thoracoabdominal aorta. J Comput Assist Tomogr 26:875–878

    Article  PubMed  Google Scholar 

  20. Henson JW, Nogueira DJ, Covarrubias R, Gonzalez RG, Lev MH (2004) Gadolinium-enhanced CT angiography of the circle of Willis and neck. M J Neuroradiol 25:969–972

    Google Scholar 

  21. Bae KT, McDermott R, Gierada DS, Heiken JP, Nolte MA, Takahashi N, Hong C (2004) Gadolinium-enhanced computed tomography angiography in multi-detector row computed tomography: initial observations. Acad Radiol 11:61–68

    Article  PubMed  Google Scholar 

  22. Wicky S, Greenfield A, Fan CM, Geller SC, Hamberg LM, Hoffmann U, Waltman AC (2004) Aortoiliac gadolinium-enhanced CT angiography: improved results with a 16-detector row scanner compared with a four-detector row scanner. J Vasc Interv Radiol 15:947–954

    PubMed  Google Scholar 

  23. Remy-Jardin M, Dequiedt P, Ertzbischoff O, Tillie-Leblond I, Bruzzi J, Duhamel A, Remy J (2005) Safety and effectiveness of gadolinium-enhanced multidetector row spiral CT angiography of the chest: results in 37 patients with contraindications to iodinated contrast agents. Radiology 235:819–826

    Article  PubMed  Google Scholar 

  24. Tombach B, Bremer C, Reimer P, Schaefer RM, Ebert W, Geens V, Heindel W (2000) Pharmacokinetics of 1 M gadobutrol in patients with chronic renal failure. Invest Radiol 35:35–40

    Article  PubMed  CAS  Google Scholar 

  25. Nyman U, Elmståhl B, Leander P, Nilsson P, Golman K, Almén T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311–318

    Article  PubMed  Google Scholar 

  26. Spinosa DJ, Kaufman JA, Hartwell GD (2002) Commentary on the viewpoint of Nyman et al. Radiology 223:328–329

    Article  Google Scholar 

  27. Thomsen HS (2003) Guidelines for contrast media from the European Society of Urogenital Radiology. AJR 181:1463–1471

    PubMed  Google Scholar 

  28. Thomsen HS, Morcos SK (2003) Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76:513–518

    Article  PubMed  CAS  Google Scholar 

  29. Elmståhl B, Nyman U, Leander P, Chai CM, Frennby B, Almén T (2004) Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal x-ray attenuation in renal arteriography: an experimental stugy in pigs. Acad Radiol 11:1219–1228

    Article  PubMed  Google Scholar 

  30. Thomsen HS (2004) Gadolinium-based contrast media may be neprhotoxic even at approved doses. Eur Radiol 14:1654–1656

    PubMed  Google Scholar 

  31. Sam AD, Morasch MD, Collins J, Song G, Chen R, Pereles S (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313–318

    Article  PubMed  Google Scholar 

  32. Staks T, Schumann-Giampieri G, Frenzel T, Weinmann HJ, Platzek J (1994) Pharmacokinetics, dose proportionality and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 29:709–715

    Article  PubMed  CAS  Google Scholar 

  33. Tombach B, Bremer C, Reimer P, Kisters K, Schaefer RM, Geens V, Heindel W (2001) Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 218:651–657

    PubMed  CAS  Google Scholar 

  34. Tombach B, Heindel W (2002) Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 12:1550–1556

    Article  PubMed  Google Scholar 

  35. Kalinowski M, Kress O, Wels T, Alfke H, Klose KJ, Wagner HJ (2003) 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study. Invest Radiol 38:193–199

    Article  PubMed  CAS  Google Scholar 

  36. Schenker MP, Solomon JA, Roberts DA (2001) Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Intervent Radiol 12:393

    Article  CAS  Google Scholar 

  37. Gemery J, Idelson B, Reid, Yucel EK, Pagan-Marin, Ali S, Casserly L (1998) Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR 171:1277–1278

    PubMed  CAS  Google Scholar 

  38. Strunk HM, Schild H (2004) Actual clinical use of gadolinium-chelates for non-MRI applications. Eur Radiol 14:1055–1062

    Article  PubMed  Google Scholar 

  39. Thomsen HS (2006) Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamine. Eur Radiol 16:2619–2621

    Article  PubMed  Google Scholar 

  40. Chicoskie C, Tello C (2005) Gadolinium-enhanced MDCT angiography of the abdomen: Feasibility and limitations. AJR 184:1821–1828

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ERESA, Department of Radiology, Consorcio Hospital General Universitario de Valencia, Avenida Tres Cruces s/n, 46014, Valencia, Spain

    José M. Esteban, Antonio Alonso, Vicente Cervera & Vicente Martínez

Authors
  1. José M. Esteban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vicente Cervera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vicente Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José M. Esteban.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esteban, J.M., Alonso, A., Cervera, V. et al. One-molar gadolinium chelate (gadobutrol) as a contrast agent for CT angiography of the thoracic and abdominal aorta. Eur Radiol 17, 2394–2400 (2007). https://doi.org/10.1007/s00330-007-0590-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-007-0590-5

Keywords

Search

Navigation